...
【24h】

Excitotoxic mechanisms and the role of astrocytic glutamate transporters in traumatic brain injury.

机译:兴奋性机制和星形细胞谷氨酸转运蛋白在颅脑外伤中的作用。

获取原文
获取原文并翻译 | 示例

摘要

Glutamate excitotoxicity plays an important role in the development of secondary injuries that occur following traumatic brain injury (TBI), and contributes significantly to expansion of the total volume of injury. Acute increases in extracellular glutamate levels have been detected in both experimental brain trauma models and in human patients, and can lead to over-stimulation of glutamate receptors, resulting in a cascade of excitotoxic-related mechanisms culminating in neuronal damage. These elevated levels of glutamate can be effectively controlled by the astrocytic glutamate transporters GLAST (EAAT1) and GLT-1 (EAAT2). However, evidence indicate these transporters and splice variant are downregulated shortly following the insult, which then precipitates glutamate-mediated excitotoxic conditions. Lack of success with glutamate receptor antagonists as a potential source of clinical intervention treatment following TBI has resulted in the necessity for a better understanding of the mechanisms that underlie the process of excitotoxicity, including the function and regulation of glutamate transporters. Such new insight should improve the likelihood of development of novel avenues for therapeutic intervention following TBI.
机译:谷氨酸兴奋性毒性在颅脑外伤(TBI)后发生的继发性损伤的发展中起重要作用,并显着促进总损伤量的扩大。在实验性脑外伤模型和人类患者中都检测到细胞外谷氨酸水平的急剧增加,并且可能导致谷氨酸受体的过度刺激,从而导致一系列与兴奋毒性相关的机制,最终导致神经元损伤。谷氨酸转运体GLAST(EAAT1)和GLT-1(EAAT2)可以有效地控制这些升高的谷氨酸水平。然而,证据表明这些转运蛋白和剪接变体在受到伤害后不久被下调,然后沉淀出谷氨酸介导的兴奋性毒性疾病。谷氨酸受体拮抗剂作为TBI后临床干预治疗的潜在来源缺乏成功,导致有必要更好地理解兴奋性毒性过程的基础机制,包括谷氨酸转运蛋白的功能和调节。这种新的见识应提高TBI后开发新的治疗干预途径的可能性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号